Two Sigma Investments, LP Cyclacel Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.75 $443 - $1,188	-1,585 Reduced 8.8%	16,424 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.52 - $0.76 $2,054 - $3,002	-3,951 Reduced 17.99%	18,009 $10,000
Q1 2023 May 15, 2023	SELL	$0.56 - $1.15 $1,176 - $2,415	-2,100 Reduced 8.73%	21,960 $12,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $21.75 $23,371 - $941,340	-43,280 Reduced 64.27%	24,060 $16,000
Q3 2022 Nov 14, 2022	BUY	$1.23 - $21.9 $82,828 - $1.47 Million	67,340 New	67,340 $98,000
Q4 2021 Feb 14, 2022	SELL	$6.04 - $8.03 $182,534 - $242,674	-30,221 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.02 - $11.0 $135,128 - $185,339	-16,849 Reduced 35.8%	30,221 $159,000
Q2 2021 Aug 16, 2021	BUY	$7.59 - $10.48 $259,691 - $358,573	34,215 Added 266.16%	47,070 $279,000
Q1 2021 May 17, 2021	BUY	$6.86 - $9.24 $88,185 - $118,780	12,855 New	12,855 $91,000

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $6.02M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.